A 16 aa MUC1 peptide conjugated to KLH plus DETOX adjuvant administered to 16 patients with metastatic breast cancer induced ab responses in only three patients, and CTL activity against MUC1-expressing tumor cell lines in seven patients [139]. The gene discussed is MUC1; the disease is neoplasm.